FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3171487666> ?p ?o ?g. }

• W3171487666 endingPage "890" @default.
• W3171487666 startingPage "883" @default.
• W3171487666 abstract "The MiniMed 670 G insulin pump system is the first commercially available hybrid closed-loop (HCL) insulin delivery system and clinical studies have shown that this device is associated with incremental benefits in glycemic control relative to continuous subcutaneous insulin infusion (CSII) with or without continuous glucose monitoring (CGM). The aim was to evaluate the long-term cost-effectiveness of the MiniMed 670 G system versus CSII alone in people with type 1 diabetes (T1D) in the UK.Cost-effectiveness analysis was performed using the IQVIA CORE Diabetes Model. Clinical input data were sourced from a clinical trial of the MiniMed 670 G system in 124 adults and adolescents with T1D. The analysis was performed over a lifetime time horizon and both future costs and clinical outcomes were discounted at 3.5% per annum. The analysis was performed from a healthcare payer perspective.The use of the MiniMed 670 G system led to an improvement in quality-adjusted life expectancy of 1.73 quality-adjusted life years (QALYs), relative to CSII. Total lifetime direct costs were GBP 35,425 higher with the MiniMed 670 G system than with CSII resulting in an incremental cost-effectiveness ratio (ICER) of GBP 20,421 per QALY gained. Sensitivity analyses revealed that the ICER was sensitive to assumptions around glycemic control and assumptions relating to the quality-of-life benefit associated with a reduction in fear of hypoglycemia.Long-term projections from short-term data are inherently associated with uncertainty but represent arguably the best available evidence in lieu of long-term clinical trials.In the UK, over patient lifetimes, the incremental clinical benefits associated with the use of MiniMed 670 G system means that it is likely to be cost-effective relative to the continued use of CSII in people with T1D, particularly for those with a fear of hypoglycemia or poor baseline glycemic control." @default.
• W3171487666 created "2021-06-22" @default.
• W3171487666 creator A5026700702 @default.
• W3171487666 creator A5031470804 @default.
• W3171487666 creator A5071516050 @default.
• W3171487666 creator A5083806277 @default.
• W3171487666 creator A5091439412 @default.
• W3171487666 date "2021-01-01" @default.
• W3171487666 modified "2023-10-11" @default.
• W3171487666 title "Cost-effectiveness of a novel hybrid closed-loop system compared with continuous subcutaneous insulin infusion in people with type 1 diabetes in the UK" @default.
• W3171487666 cites W1988587963 @default.
• W3171487666 cites W2006524439 @default.
• W3171487666 cites W2010913334 @default.
• W3171487666 cites W2020572030 @default.
• W3171487666 cites W2031432201 @default.
• W3171487666 cites W2035018400 @default.
• W3171487666 cites W2038962843 @default.
• W3171487666 cites W2039713231 @default.
• W3171487666 cites W2053071191 @default.
• W3171487666 cites W2110019707 @default.
• W3171487666 cites W2117304511 @default.
• W3171487666 cites W2131649684 @default.
• W3171487666 cites W2145583809 @default.
• W3171487666 cites W2147602249 @default.
• W3171487666 cites W2158312041 @default.
• W3171487666 cites W2169355652 @default.
• W3171487666 cites W2179459727 @default.
• W3171487666 cites W2295853094 @default.
• W3171487666 cites W2331770447 @default.
• W3171487666 cites W2468098783 @default.
• W3171487666 cites W2520448718 @default.
• W3171487666 cites W2520696266 @default.
• W3171487666 cites W2567289819 @default.
• W3171487666 cites W2567623101 @default.
• W3171487666 cites W2587843318 @default.
• W3171487666 cites W2774465513 @default.
• W3171487666 cites W2775214118 @default.
• W3171487666 cites W2780617792 @default.
• W3171487666 cites W2785745442 @default.
• W3171487666 cites W2791113526 @default.
• W3171487666 cites W2889348059 @default.
• W3171487666 cites W2897457722 @default.
• W3171487666 cites W2917355348 @default.
• W3171487666 cites W2917933379 @default.
• W3171487666 cites W2944646224 @default.
• W3171487666 cites W2954450465 @default.
• W3171487666 cites W2972530371 @default.
• W3171487666 cites W2980407603 @default.
• W3171487666 cites W2986909781 @default.
• W3171487666 cites W2993032844 @default.
• W3171487666 doi "https://doi.org/10.1080/13696998.2021.1939706" @default.
• W3171487666 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/34098834" @default.
• W3171487666 hasPublicationYear "2021" @default.
• W3171487666 type Work @default.
• W3171487666 sameAs 3171487666 @default.
• W3171487666 citedByCount "12" @default.
• W3171487666 countsByYear W31714876662021 @default.
• W3171487666 countsByYear W31714876662022 @default.
• W3171487666 countsByYear W31714876662023 @default.
• W3171487666 crossrefType "journal-article" @default.
• W3171487666 hasAuthorship W3171487666A5026700702 @default.
• W3171487666 hasAuthorship W3171487666A5031470804 @default.
• W3171487666 hasAuthorship W3171487666A5071516050 @default.
• W3171487666 hasAuthorship W3171487666A5083806277 @default.
• W3171487666 hasAuthorship W3171487666A5091439412 @default.
• W3171487666 hasBestOaLocation W31714876661 @default.
• W3171487666 hasConcept C112930515 @default.
• W3171487666 hasConcept C126322002 @default.
• W3171487666 hasConcept C134018914 @default.
• W3171487666 hasConcept C177713679 @default.
• W3171487666 hasConcept C2779306644 @default.
• W3171487666 hasConcept C2779794567 @default.
• W3171487666 hasConcept C2780473172 @default.
• W3171487666 hasConcept C2780668416 @default.
• W3171487666 hasConcept C2781232474 @default.
• W3171487666 hasConcept C2994527087 @default.
• W3171487666 hasConcept C3019080777 @default.
• W3171487666 hasConcept C555293320 @default.
• W3171487666 hasConcept C71924100 @default.
• W3171487666 hasConceptScore W3171487666C112930515 @default.
• W3171487666 hasConceptScore W3171487666C126322002 @default.
• W3171487666 hasConceptScore W3171487666C134018914 @default.
• W3171487666 hasConceptScore W3171487666C177713679 @default.
• W3171487666 hasConceptScore W3171487666C2779306644 @default.
• W3171487666 hasConceptScore W3171487666C2779794567 @default.
• W3171487666 hasConceptScore W3171487666C2780473172 @default.
• W3171487666 hasConceptScore W3171487666C2780668416 @default.
• W3171487666 hasConceptScore W3171487666C2781232474 @default.
• W3171487666 hasConceptScore W3171487666C2994527087 @default.
• W3171487666 hasConceptScore W3171487666C3019080777 @default.
• W3171487666 hasConceptScore W3171487666C555293320 @default.
• W3171487666 hasConceptScore W3171487666C71924100 @default.
• W3171487666 hasIssue "1" @default.
• W3171487666 hasLocation W31714876661 @default.
• W3171487666 hasLocation W31714876662 @default.
• W3171487666 hasOpenAccess W3171487666 @default.
• W3171487666 hasPrimaryLocation W31714876661 @default.
• W3171487666 hasRelatedWork W1977806121 @default.

• next